Orforglipron is a small molecule, nonpeptide GLP-1 receptor agonist in pill form that should be taken once a day
It has a docking effect with Src homology 2 signal molecules in cells, transferring the signal through Src homology 3 to Son of Sevenless, phosphorylating downstream Ras molecules, thereby activating the extracellular signal-related kinases (ERK1/2) pathway and regulating the growth, proliferation, and differentiation of osteoblasts [26, 27]
Loughrill, Emma, David Wray, Tatiana Christides, and Nazanin Zand
Semaglutide (Ozempic/Wegovy) : Approved in 2017 for diabetes and in 2021 for obesity, semaglutide represents the next generation of GLP-1 therapies, often leading to more significant weight loss outcomes compared to its predecessors
Slim Shot The Slim Shot is a potent combination of B12 and three crucial amino acids: choline, methionine, and inositol, which aid the liver in processing fats at an optimal level